EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs6678639 |
| Chromosomal location | Chr1: 47,104,553 (1p33) |
| Gene (distance) | CYP4A11 (-62,879) |
| Predicted causal gene | CYP4A11 |
| Gene/protein classification | metabolic enzyme |
| Metabolite (Pathway) | 10-undecenoate (11:1n1) (Medium chain fatty acid; Lipid) X-11438 (Unknown) |
| Biochemical locus-metabolite relationship | CYP4A11 encodes a fatty acid omega?hydroxylase [8274222, 10860550] with documented activity on laurate (C12:0) and palmitate (C16:0). X-11438 may be a hydroxylated tridecenoic acid (C13:1(OH)). Ratio interpretation: n/a. |
| eQTL associations | CYP4B1 (S) † |
† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;
| Medical information |
| Complex trait associations | - |
| Known metabolite associations | 10-nonadecenoate (19:1n9)/10-undecenoate (11:1n1) [21886157] |
| Inborn error of metabolism | - |
| Pharmacological information |
| ChEMBL ID | CHEMBL3978 |
| Drug information |
Presumed 10-undecenoic acid (CHEMBL1276010), an approved anti-fungal agent used to treat skin infections. No clear indication as to whether this enzyme is directly responsible for this transformation.
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |